Why It Matters
Mirum Pharmaceuticals Inc. has hired LMH Strategic Solutions LLC to represent its interests on Capitol Hill, registering as a new lobbying client on Sept. 4, 2026. The rare disease pharmaceutical company is engaging on health policy at a moment when Congress grapples with the aftermath of the One Big Beautiful Bill Act, which expanded orphan drug exemptions from Medicare price negotiation.
The Big Picture
Alanna Temme, founder of LMH Strategic Solutions LLC, is listed as the lobbyist representing Mirum. Temme previously served as Legislative Director for Rep. Jon Porter (R-NV-3) and has Congressional experience on the House Financial Services Committee and the House Education and the Workforce Committee. LMH Strategic Solutions has built a substantial pharmaceutical and biotech practice, stretching over 27 active clients and $1.2 million in past quarter revenue.
Access the Legis1 platform for comprehensive political news, data, and insights.
Spot something wrong? Report an issue with this article
